Oncogenes Come of Age

por Varmus, H., Pao*, W., Politi, K., Podsypanina, K., Du, Y.-C.N.
Publicado em 2005

Evaluation of a risk score for interhospital transport of critically ill patients

por Markakis, C, Dalezios, M, Chatzicostas, C, Chalkiadaki, A, Politi, K, Agouridakis, P J
Publicado em 2006

A dormant TIL phenotype defines non-small cell lung carcinomas sensitive to immune checkpoint blockers

por Gettinger, S. N., Choi, J., Mani, N., Sanmamed, M. F., Datar, I., Sowell, Ryan, Du, Victor Y., Kaftan, E., Goldberg, S., Dong, W., Zelterman, D., Politi, K., Kavathas, P., Kaech, S., Yu, X., Zhao, H., Schlessinger, J., Lifton, R., Rimm, D. L., Chen, L., Herbst, R. S., Schalper, K. A.
Publicado no Nat Commun (2018)

EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer

por Hastings, K, Yu, H A, Wei, W, Sanchez-Vega, F, DeVeaux, M, Choi, J, Rizvi, H, Lisberg, A, Truini, A, Lydon, C A, Liu, Z, Henick, B S, Wurtz, A, Cai, G, Plodkowski, A J, Long, N M, Halpenny, D F, Killam, J, Oliva, I, Schultz, N, Riely, G J, Arcila, M E, Ladanyi, M, Zelterman, D, Herbst, R S, Goldberg, S B, Awad, M M, Garon, E B, Gettinger, S, Hellmann, M D, Politi, K
Publicado no Ann Oncol (2019)